Literature DB >> 2380517

Avascular necrosis after scaphoid fracture: a correlation of magnetic resonance imaging and histology.

T E Trumble1.   

Abstract

In this study 12 male patients with fractures of the middle third of the scaphoid had an magnetic resonance imaging study before open reduction and internal fixation in conjunction with bone grafting of the scaphoid. The patients' average age was 27 years (range, 17 to 37 years). At the time of surgery biopsy specimens were obtained from both the proximal and distal poles of the scaphoid. The length of time before surgery ranged from a minimum of 1 1/2 months in recently displaced fractures to a maximum of 10 years in established nonunions. Results of the biopsy showed that six patients had avascular necrosis noted in the proximal pole fragment. In three of these six patients avascular necrosis was confirmed by the absence of tetracycline labeling despite positive uptake noted in biopsy specimens from the bone graft site; the other three patients did not receive tetracycline labeling. Magnetic resonance imaging showed that all six of the patients with biopsy specimens of the proximal poles showing avascular necrosis demonstrated decreased signal intensity in the proximal pole fragment, whereas the plain radiographs demonstrated changes in the proximal pole in only three of the six patients. A decreased signal intensity from the proximal pole of the scaphoid may indicate a poor prognosis inasmuch as only three of the six patients had healing of the fracture even with bone grafting and internal fixation.

Entities:  

Mesh:

Year:  1990        PMID: 2380517     DOI: 10.1016/s0363-5023(09)90015-6

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  10 in total

1.  Proximal Scaphoid Pole Reconstruction Utilizing Ipsilateral Proximal Hamate Autograft.

Authors:  Bassem Elhassan; Mohamed Noureldin; Sanjeev Kakar
Journal:  Hand (N Y)       Date:  2016-03-03

2.  Segmental fracture of the scaphoid.

Authors:  Olivia Sharp; Kai Yuen Wong; Phillip Johnston
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  Usefulness of dynamic contrast-enhanced MRI in the evaluation of the viability of acute scaphoid fracture.

Authors:  Maud Larribe; André Gay; Veronique Freire; Corinne Bouvier; Christophe Chagnaud; Philippe Souteyrand
Journal:  Skeletal Radiol       Date:  2014-08-23       Impact factor: 2.199

4.  Role of MR imaging in chronic wrist pain.

Authors:  Marco Zanetti; Nadja Saupe; Ladislav Nagy
Journal:  Eur Radiol       Date:  2006-08-24       Impact factor: 5.315

5.  Magnetic resonance imaging versus bone scintigraphy in suspected scaphoid fracture.

Authors:  M M Tiel-van Buul; W Roolker; B W Verbeeten; A H Broekhuizen
Journal:  Eur J Nucl Med       Date:  1996-08

6.  The role of MR imaging in scaphoid disorders.

Authors:  Apostolos Karantanas; Zoe Dailiana; Konstantinos Malizos
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

7.  [Operative versus conservative treatment of non-displaced fractures of the scaphoid bone. Results of a controlled multicenter cohort study].

Authors:  M Schädel-Höpfner; M Marent-Huber; M Sauerbier; T Pillukat; A Eisenschenk; H R Siebert
Journal:  Unfallchirurg       Date:  2010-10       Impact factor: 1.000

Review 8.  Scaphoid fractures and nonunions: diagnosis and treatment.

Authors:  Scott P Steinmann; Julie E Adams
Journal:  J Orthop Sci       Date:  2006-07       Impact factor: 1.601

9.  Accuracy of enhanced and unenhanced MRI in diagnosing scaphoid proximal pole avascular necrosis and predicting surgical outcome.

Authors:  M G Fox; D T Wang; A B Chhabra
Journal:  Skeletal Radiol       Date:  2015-08-02       Impact factor: 2.199

10.  A prospective multi-center cohort study of acute non-displaced fractures of the scaphoid: operative versus non-operative treatment [NCT00205985].

Authors:  Boris M Pfeiffer; Matthias Nübling; Hartmut R Siebert; Michael Schädel-Höpfner
Journal:  BMC Musculoskelet Disord       Date:  2006-05-11       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.